Lv11
80 积分 2024-12-22 加入
Predictive and prognostic value of PIK3CA mutations in HER2-positive breast cancer treated with tyrosine kinase inhibitors: A systematic review and meta-analysis
2个月前
已完结
Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline†
2个月前
已完结
Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor
5个月前
已完结
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial
7个月前
已完结
Oligometastatic Breast Cancer: Seeking the Cure by Redefining Stage IV Disease?
10个月前
已完结
皖公网安备34019202002308
